There were more patients with DM and higher GLU levels in Group II, when compared with group I. However, patients with HLAP in group I seemed to be more prone to recurrence than those in group II (24, 46% vs. 13, 26%, P = 0.034). This evidence concerns the gene HLA-P and diabetes mellitus.